Picard Medical, Inc. — Form 8-K
Filed October 6, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Picard Medical issued 3% unsecured convertible notes on September 30, 2026, maturing September 30, 2027, with principal amounts to be specified. The notes convert at the higher of $4.00/share (floor price) or equity financing price (company conversion) or market price (holder conversion). Upon conversion, holders receive one prefunded warrant per share at $0.0001 exercise price. Notes include 4.99% beneficial ownership cap for conversions and are subject to NYSE American exchange cap limitations. Specific principal amounts and holder identities are not disclosed in the template.
Why this rating
Template boilerplate for convertible instrument; principal amount and holder not specified. Without concrete dollar figures and counterparty details, cannot assess materiality relative to $130.8M market cap.
See more from October 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.